Cargando…
The Italian PrEPventHIV challenge: a scoping systematic review on HIV pre-exposure prophylaxis monitoring in Italy
BACKGROUND AND AIM: In Italy, pre-exposure prophylaxis (PrEP) with emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) was authorized for HIV prevention in 2017. This scoping systematic review summarizes current evidence on PrEP implementation in Italy since 2017. METHODS: A systematic search...
Autores principales: | Ferrara, Pietro, Gianfredi, Vincenza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335444/ https://www.ncbi.nlm.nih.gov/pubmed/35775760 http://dx.doi.org/10.23750/abm.v93i3.12766 |
Ejemplares similares
-
Perspectives of women prescribed HIV pre-exposure prophylaxis (PrEP)
por: Park, Connie, et al.
Publicado: (2017) -
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
por: Gaspar, Mark, et al.
Publicado: (2021) -
Challenges of HIV diagnosis and management in the context of pre‐exposure prophylaxis (PrEP), post‐exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review
por: Elliott, Tamara, et al.
Publicado: (2019) -
HIV Pre-Exposure Prophylaxis (PrEP)—A Quantitative Ethics Appraisal
por: Kokolo, Madzouka B., et al.
Publicado: (2011) -
HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP)
por: Zorrilla, Carmen D, et al.
Publicado: (2018)